Copy
this week on the limbic...
View this email in your browser
Welcome to the limbic. We’re a recently launched independent, free news service for cardiology health professionals. Each week we provide the latest news relevant to your specialty in one easy to read email. We’re passionate about supporting the areas we write in so we’re offering new members the chance to win a $2,000 educational travel grant. We’d love you to join us. Just click on a story link below to create a free account. 
 
New ACS guidelines. A leading Adelaide cardiologist who has spearheaded new guidelines for the treatment of acute coronary syndrome says more needs to be done to curb the inappropriate use of coronary angiography in Australia. Read More.

Grant recipient warns of funding crisis. Australia’s cardiovascular disease research has hit crisis point as a lack of funding drives scientists in other, more lucrative research fields, says one of the country’s most senior cardiovascular researchers. Read More.
 
Is 80 the new 60? Interventional cardiologist Dr Brahmajee Nallamothu from the Ann Arbor VA Medical Center in Michigan gave CSANZ2016 delegates five points to contemplate when considering elderly patients for cardiac surgery. Read More.
Top tips for getting published. The editors of four leading cardiology journals have shared some of the secrets to success when submitting research for publication. Read More.
 
HFPEF an emerging epidemic. Delivering this year’s Kempson-Maddox lecture Professor David Kaye, Associate Director of Baker IDI Heart and Diabetes Institute, tells delegates five key things they should know about the ’emerging epidemic’ of heart failure with preserved ejection fraction. Read More.
 
Does AF cause stroke? Is it a direct cause or the company it keeps? This is the tricky question Associate Professor Andrew McGavigan was tasked with answering during a session on controversies in stroke prevention in atrial fibrillation. Read More.
 
The future of PCSK9 inhibitors takes a twist. Reports this week that Pfizer intends to shelve the development of its oral PCSK9 inhibitor suggest the future of this therapy may remain in injectables. Read More.
 
Predicting high-risk heart failure patients. The prestigious Ralph Reader prize for clinical science has been awarded to a researcher from Tasmania who developed a risk prediction tool to identify heart failure patients at the highest risk of death or readmission. Read More.
 
New BP guidelines. New hypertension guidelines recommend a lower target of 120mmHg systolic BP for patients with a moderate cardiovascular risk. Read More.
 
More news on the limbic cardiology
 
Top 10 most commonly prescribed drugs. Statins and blood pressure drugs make up eight out the ten. Read More.

 You say 'Noac' and I say 'DOAC. The ageing of ‘novel’ or ‘new’ anticoagulants (NOACs) and the imprecise description of the class has prompted calls for a new name – and the likely contender is DOACs. Read More. 

Fears over 'Trip-Advisor' style doctor site. The website run by several private health insurers may lead to doctors avoiding treating high-risk patients  the AMA says. Read More. 

Please send any news or comments to editor@thelimbic.com. Follow us on twitter @thelimbiccardio for updates throughout the day.
Copyright © 2016, Limbic Digital Media, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list